Reinsurance Group of America is upgraded to 'buy' after robust financial and underwriting results, with shares up 36% since the last review. RGA's unique focus on long-duration life and pension risk, coupled with strong claims experience and medical advancements, underpins its differentiated return profile. Investment returns have significantly outperformed peers, with alternative investments yielding 15% annualized in Q2 and new money yields expected to rise to 6.5%.








